PSCR.US Proto Script Pharmaceutical Corp
- Market cap
- USD 4.91K
- P/E
- -
- P/B
- -
- ROE
- -
- Dividend yield
- 1,212.72%
- Fundamental score
- -
Ratios use the latest price and the fiscal year ending Dec 2022.
Is PSCR.US undervalued?
Graham numberThe Graham number of Proto Script Pharmaceutical Corp cannot be estimated reliably (it needs positive earnings and book value).
Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?
Proto Script Pharmaceutical Corp fundamental analysis
No fundamental analysis for Proto Script Pharmaceutical Corp yet.
Proto Script Pharmaceutical Corp stock price
Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.
About Proto Script Pharmaceutical Corp
Proto Script Pharmaceutical Corp. engages in the repair and rental of power wheelchairs and scooters. The company serves federal, state, and private insurance providers. Proto Script Pharmaceutical Corp. was founded in 2001 and is headquartered in Rancho Cucamonga, California.
Full company profileProto Script Pharmaceutical Corp financial statements
Proto Script Pharmaceutical Corp annual financial statements (USD; K = thousand, M = million, B = billion, T = trillion)
| Item | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2019 | 2020 | 2021 | 2022 |
|---|---|---|---|---|---|---|---|---|---|---|
| Income Statement | ||||||||||
| Revenue | - | - | - | 948K | 881K | 789K | - | - | - | - |
| Gross Profit | - | - | - | 690K | 694K | 564K | - | - | - | - |
| Operating Income | -32.8K | -32.4K | -38.3K | -232K | -147K | -298K | - | - | - | - |
| EBITDA | -32.8K | -32.4K | -38.3K | - | -70.8K | -293K | - | - | - | - |
| Net Income | -32.8K | -32.4K | -38.3K | -239K | -145K | -7.18M | - | - | - | - |
| EPS | 0.00 | 0.00 | 0.00 | - | 0.00 | -0.08 | - | - | - | - |
| Balance Sheet | ||||||||||
| Total Assets | 60.6K | 36.0K | 311.00 | 454K | 199K | 170K | - | - | - | - |
| Total Liabilities | 8.77K | 8.14K | 28.3K | 130K | 137K | 490K | - | - | - | - |
| Shareholders' Equity | 51.8K | 27.9K | -28.0K | 324K | 62.2K | -320K | - | - | - | - |
| Cash & Short-term Investments | 59.6K | 35.0K | 40.00 | 31.2K | 9.09K | 3.51K | - | - | - | - |
| Total Debt | - | - | - | - | 36.2K | 51.3K | - | - | - | - |
| Cash Flow | ||||||||||
| Operating Cash Flow | -23.7K | -32.0K | -32.5K | -122K | 38.1K | 44.1K | - | - | - | - |
| Capital Expenditure | 0.00 | 0.00 | 0.00 | 2.08K | 6.06K | 15.2K | - | - | - | - |
| Free Cash Flow | -23.7K | -32.0K | -32.5K | - | 32.0K | 28.9K | - | - | - | - |
| Ratios | ||||||||||
| ROE | -63.4% | -116.3% | - | -73.9% | -233.4% | - | - | - | - | - |
| ROA | -54.2% | -90.0% | -12,301.9% | -52.7% | -73.0% | -4,220.4% | - | - | - | - |
| Net Profit Margin | - | - | - | -25.2% | -16.5% | -910.4% | - | - | - | - |
| Debt to Equity | - | - | - | - | 0.58x | - | - | - | - | - |
What these items mean
- Revenue
- Total sales of goods and services in the period.
- Gross Profit
- Revenue minus the direct cost of producing what was sold.
- Operating Income
- Profit from the core business after operating expenses.
- EBITDA
- Earnings before interest, taxes, depreciation and amortization.
- Net Income
- Profit left for shareholders after all expenses, interest and taxes.
- EPS
- Net income divided by shares outstanding.
- Total Assets
- Everything the company owns.
- Total Liabilities
- Everything the company owes.
- Shareholders' Equity
- Assets minus liabilities: the book value that belongs to shareholders.
- Cash & Short-term Investments
- Cash and investments that can be turned into cash quickly.
- Total Debt
- Short and long-term borrowings.
- Operating Cash Flow
- Cash generated by the core business.
- Capital Expenditure
- Cash spent on property, plant and equipment.
- Free Cash Flow
- Operating cash flow minus capital expenditure: cash left for dividends, buybacks or debt repayment.
- ROE
- Return on equity: net income divided by shareholders' equity.
- ROA
- Return on assets: net income divided by total assets.
- Net Profit Margin
- Net income as a share of revenue.
- Debt to Equity
- Total debt divided by shareholders' equity.
Proto Script Pharmaceutical Corp dividends
- Dividend yield
- 1,212.72%
- Forward dividend
- -
- Payout ratio
- -
- Ex-dividend date
- -
| Fiscal year | Dividends paid | Per share | Payout ratio |
|---|---|---|---|
| 2016 | USD 59.6K | 0.00 | - |
| 2015 | USD 90.2K | 0.00 | - |
| 2014 | - | - | - |
| 2013 | - | - | - |
| 2012 | - | - | - |
| 2011 | - | - | - |
From the cash flow statement: dividends paid in the fiscal year, divided by that year's shares outstanding. Payout ratio = dividends paid / net income.
Last stock split: 10:1 on Oct 13, 2016.
Who owns Proto Script Pharmaceutical Corp
- Insiders 10.18%
- Institutions 0.00%
- Public & others 89.83%
- Shares outstanding 49.1M
- Free float 44.8M
Proto Script Pharmaceutical Corp company profile
- Company name
- Proto Script Pharmaceutical Corp
- Ticker
- PSCR.US
- Exchange
- USA Stocks
- Sector
- Industrials
- Industry
- Commercial Services & Supplies
- Fiscal year end
- December
- Address
- 9830 6th Street, Rancho Cucamonga, CA, United States, 91730
- Phone
- 855-476-7679
- Website
- psphomecare.com
About Proto Script Pharmaceutical Corp
Proto Script Pharmaceutical Corp. engages in the repair and rental of power wheelchairs and scooters. The company serves federal, state, and private insurance providers. Proto Script Pharmaceutical Corp. was founded in 2001 and is headquartered in Rancho Cucamonga, California.
Proto Script Pharmaceutical Corp management
1- Ms. Michelle RicoPresident, CEO, CFO, Secretary, Treasurer & Director · born 1968